about
Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networksComparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumorsBevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II studyPhase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas.CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.Inhibition of angiogenesis in cancer patients.Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapyThe novel antiangiogenic VJ115 inhibits the NADH oxidase ENOX1 and cytoskeleton-remodeling proteinsTranslational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort.Alpha-v integrins as therapeutic targets in oncology.
P2860
Q30475052-AB9C9536-A40D-442E-A40A-7833DCDB3759Q33368027-89ECC823-5F79-44C2-98AE-6FB7532290EBQ33384793-80CE56EF-6296-4BA9-8236-25CB2C717B65Q34491021-F80E6F33-360F-4CD7-B126-73F087B75E1EQ35776891-A3BA36E3-F4A2-4627-A0AA-056C0D8482B6Q36150646-570C9139-1818-4D5E-9E79-C2A0B7D2770CQ36297117-289A464B-8F4D-44CD-92D6-5E725DFF4D56Q36556901-FCD02859-B202-4C0A-A720-8098ECA8F098Q36910794-6EBD6EC1-E649-4457-8395-8AF6FA711932Q37008623-E22308C6-F821-4CEF-B04C-839CD0FAC44A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Expanding the clinical development of bevacizumab.
@ast
Expanding the clinical development of bevacizumab.
@en
type
label
Expanding the clinical development of bevacizumab.
@ast
Expanding the clinical development of bevacizumab.
@en
prefLabel
Expanding the clinical development of bevacizumab.
@ast
Expanding the clinical development of bevacizumab.
@en
P1433
P1476
Expanding the clinical development of bevacizumab.
@en
P2093
Helen X Chen
P356
10.1634/THEONCOLOGIST.9-SUPPL_1-27
P478
P577
2004-01-01T00:00:00Z